In conclusion, our study demonstrates that tumor growth retardation is primarily a cumulative effect of MG132-mediated stabilization of Fas levels on tumor cells, and MMC-induced expression of FasL in TAMs and tumor cells (Figure 8). This evidence concerns the gene FASLG and neoplasm.